virbagen omega
virbac s.a. - rekombinantti omena-interferoni kissan alkuperää - immunostimulantit, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. fiv: llä infektoiduilla kissoilla kuolleisuus oli alhainen (5%), eikä hoito vaikuttanut siihen.
kestine lyo 10 mg tabletti, kylmäkuivattu
almirall sa - ebastine - tabletti, kylmäkuivattu - 10 mg - ebastiini
kestine lyo 20 mg tabletti, kylmäkuivattu
almirall sa - ebastine - tabletti, kylmäkuivattu - 20 mg - ebastiini
nebido 1000 mg / 4 ml injektioneste, liuos
grÜnenthal gmbh - testosterone undecanoate - injektioneste, liuos - 1000 mg / 4 ml - testosteroni
primolut n 5 mg tabletti
bayer oy - norethisterone - tabletti - 5 mg - noretisteroni
remeron 15 mg tabletti, kalvopäällysteinen
n.v. organon - mirtazapinum - tabletti, kalvopäällysteinen - 15 mg - mirtatsapiini
remeron 30 mg tabletti, kalvopäällysteinen
n.v. organon - mirtazapinum - tabletti, kalvopäällysteinen - 30 mg - mirtatsapiini
remeron 45 mg tabletti, kalvopäällysteinen
n.v. organon - mirtazapinum - tabletti, kalvopäällysteinen - 45 mg - mirtatsapiini
remeron 15 mg/ml oraaliliuos
n.v. organon - mirtazapinum - oraaliliuos - 15 mg/ml - mirtatsapiini
remeron soltab 30 mg tabletti, suussa hajoava
paranova oy - mirtazapinum - tabletti, suussa hajoava - 30 mg - mirtatsapiini